Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50041362
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422558(CHEMBL434705)
Affinity DataIC50: 79.4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422531(UCB-34714 | BRIVARACETAM)
Affinity DataIC50: 100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422517(CHEMBL149348)
Affinity DataIC50: 100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422548(CHEMBL150241)
Affinity DataIC50: 125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422518(CHEMBL358242)
Affinity DataIC50: 125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422525(CHEMBL348187)
Affinity DataIC50: 158nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422519(CHEMBL358393)
Affinity DataIC50: 199nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422522(CHEMBL347071)
Affinity DataIC50: 251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422540(CHEMBL152911)
Affinity DataIC50: 251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422533(CHEMBL150331)
Affinity DataIC50: 398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422526(CHEMBL359062)
Affinity DataIC50: 398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422556(CHEMBL358161)
Affinity DataIC50: 501nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422523(CHEMBL358239)
Affinity DataIC50: 794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422542(UCB-22059 | UCB-L059 | Keppra | Keppra Xr | Leveti...)
Affinity DataIC50: 794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422544(CHEMBL154983)
Affinity DataIC50: 1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422545(CHEMBL345318)
Affinity DataIC50: 1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422555(CHEMBL346223)
Affinity DataIC50: 1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422541(CHEMBL149400)
Affinity DataIC50: 1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422549(CHEMBL150791)
Affinity DataIC50: 1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422536(CHEMBL421785)
Affinity DataIC50: 1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422551(CHEMBL358877)
Affinity DataIC50: 1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422534(CHEMBL153282)
Affinity DataIC50: 1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422553(CHEMBL151650)
Affinity DataIC50: 1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422543(CHEMBL153264)
Affinity DataIC50: 1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422532(CHEMBL150281)
Affinity DataIC50: 2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422538(CHEMBL154863)
Affinity DataIC50: 2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422552(CHEMBL153690)
Affinity DataIC50: 2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422529(CHEMBL150393)
Affinity DataIC50: 3.16E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422524(CHEMBL440539)
Affinity DataIC50: 3.98E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422527(CHEMBL151072)
Affinity DataIC50: 3.98E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422550(CHEMBL2111197)
Affinity DataIC50: 5.01E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422554(CHEMBL607297)
Affinity DataIC50: 6.30E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422557(CHEMBL607346)
Affinity DataIC50: 6.30E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422520(CHEMBL150903)
Affinity DataIC50: 9.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422521(CHEMBL607343)
Affinity DataIC50: 1.25E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422537(CHEMBL153180)
Affinity DataIC50: 1.25E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422530(CHEMBL346199)
Affinity DataIC50: 1.58E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422546(CHEMBL153729)
Affinity DataIC50: 1.99E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422535(CHEMBL607399)
Affinity DataIC50: 1.99E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422539(CHEMBL153619)
Affinity DataIC50: 1.99E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422547(CHEMBL154929)
Affinity DataIC50: 2.51E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM62877(2-(2-oxopyrrolidin-1-yl)acetamide | PIRACETAM | ci...)
Affinity DataIC50: 3.98E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422528(CHEMBL150456)
Affinity DataIC50: 6.30E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50001546(Levitiracetam)
Affinity DataIC50: 9.99E+5nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed
TargetSynaptic vesicle glycoprotein 2A(Rat)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50409889(CHEMBL2111255)
Affinity DataIC50: 9.99E+5nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2013
Entry Details Article
PubMed